Nearly half of weight loss participants reduced alcohol use after starting anti-obesity medication
Anti-obesity medications linked to reduced alcohol use, possibly due to effects on cravings and reward systems, with behavioral strategies also ...
Tag: Glucagon
GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder
A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use disorder hospitalizations, highlighting the potential ...
Semaglutide improves heart health and reduces weight in obese patients, but with side effects
Study shows that semaglutide not only aids in weight loss but also slashes heart failure risk by 76% in overweight ...
GLP-1 receptor agonists show promise in treating substance use disorders
A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due ...
Clarification urgently needed for detected signal of semaglutide-linked suicidal ideation
Study: Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality. Image Credit: myskin / Shutterstock.com In a recent ...
Semaglutide may reduce smoking risks for diabetes patients
In a recent study published in the journal Annals of Internal Medicine, a team of researchers from the National Institutes ...
Twincretin drug Tirzepatide shows unmatched efficacy in weight loss and diabetes management
In a recent review published in the journal Frontiers Endocrinology, researchers collate and elucidate recent clinical and pathophysiological knowledge on ...
Anti-obesity medications slash heart disease risk in obese patients, study finds
Obesity is a major cause of illness and death, mainly due to cardiovascular disease (CVD), which claims about 18 million ...
Sustainable weight loss with personalized semaglutide dosing
New research being presented at the European Congress on Obesity (ECO) in Venice, Italy (12-15 May) has explored the benefits ...
How safe are GLP-1R agonists in early pregnancy?
A new study published in JAMA Internal Medicine examines the safety of glucagon-like peptide 1 (GLP-1) receptor agonists, along with ...
